ATE96032T1 - Verfahren zur herstellung von aloe-erzeugnissen. - Google Patents

Verfahren zur herstellung von aloe-erzeugnissen.

Info

Publication number
ATE96032T1
ATE96032T1 AT89902414T AT89902414T ATE96032T1 AT E96032 T1 ATE96032 T1 AT E96032T1 AT 89902414 T AT89902414 T AT 89902414T AT 89902414 T AT89902414 T AT 89902414T AT E96032 T1 ATE96032 T1 AT E96032T1
Authority
AT
Austria
Prior art keywords
manufacture
aloe products
polysaccharidic
substance
aloe
Prior art date
Application number
AT89902414T
Other languages
English (en)
Inventor
Bill H Mcanalley
Original Assignee
Carrington Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carrington Lab Inc filed Critical Carrington Lab Inc
Application granted granted Critical
Publication of ATE96032T1 publication Critical patent/ATE96032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment
AT89902414T 1988-01-14 1989-01-12 Verfahren zur herstellung von aloe-erzeugnissen. ATE96032T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/144,872 US4851224A (en) 1986-06-05 1988-01-14 Process for preparation of aloe products
PCT/US1989/000036 WO1989006539A1 (en) 1988-01-14 1989-01-12 Process for preparation of aloe products

Publications (1)

Publication Number Publication Date
ATE96032T1 true ATE96032T1 (de) 1993-11-15

Family

ID=22510513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89902414T ATE96032T1 (de) 1988-01-14 1989-01-12 Verfahren zur herstellung von aloe-erzeugnissen.

Country Status (12)

Country Link
US (1) US4851224A (de)
EP (1) EP0356484B1 (de)
JP (1) JP2832551B2 (de)
KR (1) KR930001062B1 (de)
CN (1) CN1034313A (de)
AT (1) ATE96032T1 (de)
AU (1) AU3060289A (de)
CA (1) CA1312860C (de)
DE (1) DE68910051T2 (de)
MX (1) MX168996B (de)
WO (1) WO1989006539A1 (de)
ZA (1) ZA889733B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
US5118673A (en) * 1982-05-07 1992-06-02 Carrington Laboratories, Inc. Uses of aloe products
CA1328074C (en) * 1988-09-01 1994-03-29 Shigenori Tanaka Horseshoe crab amebocyte lysate factor g inhibitor
KR0141685B1 (ko) * 1988-09-01 1998-07-01 야마따니 와따루 참게 아메보사이트 라이세이트 g 인자 활성화 저해제
JP2514102B2 (ja) 1990-06-13 1996-07-10 ユリカ株式会社 ユリ科アロエ属に属する植物の真空凍結乾燥体を利用した錠剤製品及びその製造方法
US5316768A (en) * 1990-12-28 1994-05-31 Murdock International Corporation Pharmaceutical compositions having antiviral activity against human cytomegalovirus
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5902796A (en) * 1995-09-22 1999-05-11 Carrington Laboratories, Inc. Bioactive factors of aloe vera plants
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US5824659A (en) * 1996-09-04 1998-10-20 Board Of Regents, The University Of Texas System Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation
US6303584B1 (en) 1996-11-20 2001-10-16 The University Of Montana Water soluble lipidated arabinogalactan
WO1999019505A1 (en) 1997-10-10 1999-04-22 Univera Pharmaceuticals, Inc. Process for the preparation of immunomodulatory polysaccharides from aloe
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
CN1088372C (zh) * 1998-11-24 2002-07-31 成都赛维芦荟制品有限公司 保鲜芦荟片的制备方法
US6630152B2 (en) * 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
US6541678B2 (en) * 1999-09-27 2003-04-01 Brennen Medical, Inc. Immunostimulating coating for surgical devices
US7326404B2 (en) * 2000-05-31 2008-02-05 Vuksan Holdings Inc. Konjac-mannan and ginseng compositions and methods and uses thereof
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6884783B2 (en) * 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
US7318374B2 (en) 2003-01-21 2008-01-15 Victor Guerrero Wire cloth coffee filtering systems
US7060304B2 (en) * 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
JP2007516156A (ja) * 2003-10-28 2007-06-21 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ 胃潰瘍治療のための新規ハーブ組成物
US7461587B2 (en) 2004-01-21 2008-12-09 Victor Guerrero Beverage container with wire cloth filter
CN101804144A (zh) * 2005-09-22 2010-08-18 森永乳业株式会社 内脏脂肪蓄积抑制剂
RU2356572C1 (ru) 2005-11-25 2009-05-27 Моринага Милк Индастри Ко., Лтд. Экстракт алоэ вера, метод получения экстракта алоэ вера и снижающий гипергликемию агент
TWI454261B (zh) 2007-01-09 2014-10-01 Unigen Inc 作為治療劑之色酮類
JP5693218B2 (ja) 2007-05-11 2015-04-01 アロエバイオティクス・リサーチ・ラブズ，インコーポレイテッド 皮膚強化用アロエ製剤
US9433805B2 (en) * 2007-10-04 2016-09-06 Ultraceuticals R&D Pty Ltd. Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition
KR101717301B1 (ko) * 2008-10-14 2017-03-16 네리엄 바이오테크놀로지, 인크. 강심 배당체의 추출방법 및 조성물
US7833829B2 (en) * 2008-10-28 2010-11-16 Honeywell International Inc. MEMS devices and methods of assembling micro electromechanical systems (MEMS)
KR101086227B1 (ko) 2009-12-29 2011-11-23 주식회사 코리아나화장품 나도개감채 추출물을 유효성분으로 함유하는 화장료 조성물
US8604187B2 (en) 2010-01-14 2013-12-10 North Texas Medical Associates Compositions and methods of aloe polysaccharides
BR112013001717A2 (pt) * 2010-07-23 2016-05-31 North Texas Medical Ass tratamento de síndrome de imunodeficiência adquirida (aids) com propriedades antivirais de aloe vera
JP6158089B2 (ja) * 2010-11-23 2017-07-05 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 生きている、収穫された海藻からフコイダン及びラミナリンを単離するための方法
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
EP4014983A1 (de) * 2015-04-13 2022-06-22 Capsulent Lösungen mit einer kombination aus fettpflanzenextrakt und alginat und produkte damit
WO2018222902A1 (en) 2017-06-02 2018-12-06 Extreme Fire Solutions, Llc Fire extinguishing systems and compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362951A (en) * 1965-12-21 1968-01-09 Farkas Alexander Polysaccharide product derived from the juice of the aloe plant and methods for preparing same
US3360511A (en) * 1966-11-22 1967-12-26 Farkas Alexander Aloe polysaccharide composition and its preparation
US3892853A (en) * 1967-05-22 1975-07-01 Aloe 99 & 0 Inc Stabilized aloe vera gel and preparation of same
US3920816A (en) * 1967-12-29 1975-11-18 Vis Mediatrix Naturae Scient L Composition for treating respiratory diseases
US4178372A (en) * 1978-03-06 1979-12-11 Coats Billy C Hypoallergenic stabilized aloe vera gel
US4555987A (en) * 1983-07-22 1985-12-03 Tumlinson Larry N Method and apparatus for extraction of aloe vera gel
EP0328775B1 (de) * 1985-06-28 1993-10-20 Carrington Laboratories, Inc. Verfahren zur Herstellung von Aloe-Erzeugnissen, Erzeugnisse und Zusammensetzungen dazu

Also Published As

Publication number Publication date
WO1989006539A1 (en) 1989-07-27
KR930001062B1 (ko) 1993-02-15
EP0356484A1 (de) 1990-03-07
CA1312860C (en) 1993-01-19
CN1034313A (zh) 1989-08-02
EP0356484B1 (de) 1993-10-20
DE68910051D1 (de) 1993-11-25
DE68910051T2 (de) 1994-05-05
JP2832551B2 (ja) 1998-12-09
US4851224A (en) 1989-07-25
MX168996B (es) 1993-06-16
JPH02503094A (ja) 1990-09-27
ZA889733B (en) 1990-08-29
EP0356484A4 (de) 1990-02-05
AU3060289A (en) 1989-08-11
KR900700118A (ko) 1990-08-11

Similar Documents

Publication Publication Date Title
ATE96032T1 (de) Verfahren zur herstellung von aloe-erzeugnissen.
DE3884973T2 (de) Verfahren zur Herstellung von Avermectine-B und die verwendeten Kulturen.
DE68915246D1 (de) Verfahren zur dynamischen und zentralen Verwaltung eines Fernverarbeitungsnetzwerkes.
DE3789881T2 (de) Verfahren zur Herstellung von Photomasken und Photomaske.
DE69313908D1 (de) Verfahren zur Herstellung von modifizierten Polysacchariden und modifizierte Polysaccharide
AU1889188A (en) Process and plant for series coating of parts
FR2617488B1 (fr) Procede de fabrication de structures organisees de collagene, notamment d'origine humaine, et structures organisees de collagene correspondantes
DE69011951D1 (de) Verfahren zur Behandlung und Herstellung von Material.
DE68927949D1 (de) 3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen
DE69003009T2 (de) Verfahren zur Behandlung von Fasermaterialien.
DE68928398T2 (de) Verfahren zur Herstellung von Polybuten
DE69024244D1 (de) Verfahren zur Herstellung von supraleitendem Material auf Bismuth-Basis
DE69030836D1 (de) Material und Verfahren zur Herstellung von Mikromustern
DE3851364T2 (de) Verfahren zur Herstellung von supraleitendem Material.
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE69029234T2 (de) Verfahren zur Herstellung von Dünnschichtsupraleitern und supraleitenden Einrichtungen
DE69321885D1 (de) Verfahren zur fermentativen Herstellung von 10-Hydroxy-C18-Carbonsäure und Gamma-Dodekalaktonderivaten
DE3855357D1 (de) Verfahren zur Herstellung von supraleitenden Keramiken
DE69013726D1 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
DE3788491D1 (de) Energiehärtbare druckempfindliche Klebstoffe und Verfahren zur Herstellung von druckempfindlichen Klebstoffen.
IT7868964A0 (it) Metodo di racemizzazione del d oi tetramisolo e prodotto relativo
DE69018539T2 (de) Verfahren zur Herstellung von supraleitenden Dünnschichten.
DE3791059T1 (de) Zementierverfahren und -anlage
DE355981T1 (de) Verfahren zur Herstellung von Nla IV Restriktionsendonuklease und -methylase.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee